An investment professional who also stands out as a physician and medical professor, Dr. Mitchell Blutt currently serves as the CEO of Consonance Capital, a New York City-based investment firm. One of the first to specialize in health care-related investments, Dr. Mitchell Blutt has served on the boards for numerous organizations, including the board of trustees of the Perelman School of Medicine at the University of Pennsylvania. Recently, the Perelman School of Medicine announced that two members of its faculty won highly competitive Sloan Research Fellowships, which includes $65,000 in research funding. Since 1955, the fellowship has been awarded to young scholars who demonstrate they are among the most promising scientific researchers in their field. Fellowships are given in the areas of economics, chemistry, molecular biology, mathematics, neuroscience, and other fields. An assistant professor of neuroscience, Shinjae Chung, Ph.D., and an assistant professor of genetics, Iain Mathieson, Ph.D., received the Sloan award in 2018. Dr. Chung will use her fellowship to study the mechanisms that control sleep and their relationship to the circuits that regulate emotional states. Dr. Mathieson plans to use his fellowship to study human genetic structure and how it has impacted human evolution and disease throughout history.
0 Comments
Leave a Reply. |
AuthorMaintaining an assortment of professional affiliations, Mitchell Blutt, MD, serves as founder and chief executive officer of Manhattan-based healthcare investment firm Consonance Capital. ArchivesCategories |